Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A radioimmunoassay for isoniazid.

R Schwenk, K Kelly, K S Tse

    Clinical Chemistry
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    A new radioimmunoassay accurately measures isoniazid drug levels in patients. This method helps understand isoniazid pharmacokinetics during therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conjugates of ovalbumin and monomethoxypolyethylene glycol abolish late allergic responses and decrease IL-4 and IL-5 mRNA expression in the rat.

    Pulmonary pharmacology & therapeutics·2003
    Same author

    Integration of holistic nursing care in the treatment of asthma: a case study.

    Journal of emergency nursing·1998
    Same author

    Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles.

    The American journal of physiology·1998
    Same author

    Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?

    Lung cancer (Amsterdam, Netherlands)·1998
    Same author

    A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection.

    Infection and immunity·1998
    Same author

    Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998

    Area of Science:

    • Pharmacology
    • Clinical Chemistry
    • Analytical Chemistry

    Background:

    • Isoniazid is a critical first-line treatment for tuberculosis.
    • Accurate measurement of isoniazid plasma concentrations is essential for optimizing therapeutic efficacy and minimizing toxicity.
    • Existing methods for isoniazid quantification may lack the sensitivity required for therapeutic and subtherapeutic ranges.

    Purpose of the Study:

    • To develop and validate a sensitive radioimmunoassay for quantifying isoniazid.
    • To assess the utility of this assay in an exploratory clinical setting.
    • To determine isoniazid plasma concentrations over time in patients undergoing therapy.

    Main Methods:

    • Development of a radioimmunoassay (RIA) for isoniazid.
    • Validation of the RIA for sensitivity, specificity, and precision.

    Related Experiment Videos

  • Application of the RIA in an exploratory clinical study involving patients receiving isoniazid therapy.
  • Serial plasma sampling and analysis to measure drug concentration as a function of time.

    • Main Results:

    • The developed radioimmunoassay demonstrated high sensitivity, capable of measuring both therapeutic and subtherapeutic isoniazid concentrations.
    • The study successfully measured isoniazid plasma levels in patients over the course of their treatment.
    • Exploratory data on drug concentration profiles as a function of time were obtained.

    Conclusions:

    • The sensitive radioimmunoassay provides a reliable tool for monitoring isoniazid levels in clinical practice.
    • This assay facilitates pharmacokinetic studies and therapeutic drug monitoring for isoniazid.
    • Further studies can utilize this method to optimize isoniazid dosing regimens and improve patient outcomes.